Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Halozyme plunges 50% on FDA setback
Halozyme plunges 50% on FDA setback
Halozyme plunges 50% on FDA setback
Submitted by
admin
on August 2, 2012 - 12:31pm
Source:
Marketwatch
News Tags:
Halozyme
FDA
HyQ
Baxter International
Headline:
Halozyme plunges 50% on FDA setback
Do Not Allow Advertisers to Use My Personal information
